Literature DB >> 10930055

Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption.

G Shepherd1, W Klein-Schwartz, A H Burstein.   

Abstract

BACKGROUND: Iron is not bound by charcoal; therefore, a method of binding iron in the gastrointestinal tract to prevent absorption in iron overdose is needed. This study investigated the efficacy and safety of sodium polystyrene sulfonate to prevent absorption of iron in human volunteers.
METHODS: Six adult volunteers completed this prospective crossover trial. Following an oral dose of elemental iron 10 mg/kg, each subject received sodium polystyrene sulfonate 30 g or water as control. Baseline and serial serum iron samples were drawn to determine pharmacokinetic parameters.
RESULTS: A trend toward increased time to peak following sodium polystyrene sulfonate compared to the control arm (5.7 vs 3.6 hours) was observed but was not statistically significant (p = 0.517). A trend toward smaller area-under-the-curve for the sodium polystyrene sulfonate was evident but was not statistically significant (p = 0.77). Iron concentration increased on average 298 mcg/dL and 370 mcg/dL above baseline in the treatment and control arms (p = 0.44). Sodium polystyrene sulfonate is not an effective method of decontamination for iron overdose.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930055     DOI: 10.1081/clt-100100948

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  3 in total

1.  Detoxification of gold nanorods by treatment with polystyrenesulfonate.

Authors:  Alexei P Leonov; Jiwen Zheng; Jeffrey D Clogston; Stephan T Stern; Anil K Patri; Alexander Wei
Journal:  ACS Nano       Date:  2008-12-23       Impact factor: 15.881

2.  Inflammatory response to intravitreal injection of gold nanorods.

Authors:  Michelle Gabriele Sandrian; Gadi Wollstein; Joel S Schuman; Richard A Bilonick; Yun Ling; Hiroshi Ishikawa; Larry Kagemann; Kyle C McKenna
Journal:  Br J Ophthalmol       Date:  2012-10-19       Impact factor: 4.638

3.  Sodium polystyrene sulfonate (Kayexalate) aspiration.

Authors:  Luis F Gonzalez-Cuyar; Nathaniel B Cresswell; Allen P Burke
Journal:  Diagn Pathol       Date:  2008-06-17       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.